Compare Fulford India with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs ALEMBIC LTD - Comparison Results

FULFORD INDIA     Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA ALEMBIC LTD FULFORD INDIA/
ALEMBIC LTD
 
P/E (TTM) x 398.8 73.7 540.9% View Chart
P/BV x 6.2 2.6 237.3% View Chart
Dividend Yield % 0.1 0.4 21.7%  

Financials

 FULFORD INDIA   ALEMBIC LTD
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
ALEMBIC LTD
Mar-18
FULFORD INDIA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs94272 1,308.3%   
Low Rs45034 1,327.4%   
Sales per share (Unadj.) Rs691.44.7 14,708.4%  
Earnings per share (Unadj.) Rs11.56.1 187.8%  
Cash flow per share (Unadj.) Rs15.46.2 245.9%  
Dividends per share (Unadj.) Rs2.000.20 1,000.0%  
Dividend yield (eoy) %0.30.4 76.1%  
Book value per share (Unadj.) Rs380.040.7 934.6%  
Shares outstanding (eoy) m3.90267.03 1.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.011.3 8.9%   
Avg P/E ratio x60.78.7 700.0%  
P/CF ratio (eoy) x45.38.5 534.5%  
Price / Book Value ratio x1.81.3 140.6%  
Dividend payout %17.43.3 532.5%   
Avg Mkt Cap Rs m2,71414,139 19.2%   
No. of employees `0000.4NA-   
Total wages/salary Rs m505207 243.5%   
Avg. sales/employee Rs Th6,073.0NM-  
Avg. wages/employee Rs Th1,137.4NM-  
Avg. net profit/employee Rs Th100.7NM-  
INCOME DATA
Net Sales Rs m2,6961,255 214.8%  
Other income Rs m125370 33.9%   
Total revenues Rs m2,8221,625 173.6%   
Gross profit Rs m-46111 -41.8%  
Depreciation Rs m1538 40.2%   
Interest Rs m102 558.8%   
Profit before tax Rs m54442 12.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1024 40.1%   
Profit after tax Rs m451,630 2.7%  
Gross profit margin %-1.78.9 -19.4%  
Effective tax rate %17.75.4 326.1%   
Net profit margin %1.7129.8 1.3%  
BALANCE SHEET DATA
Current assets Rs m1,7381,867 93.1%   
Current liabilities Rs m545591 92.1%   
Net working cap to sales %44.3101.6 43.5%  
Current ratio x3.23.2 101.0%  
Inventory Days Days4894 51.4%  
Debtors Days Days474 5.9%  
Net fixed assets Rs m121,791 0.7%   
Share capital Rs m39534 7.3%   
"Free" reserves Rs m1,44310,324 14.0%   
Net worth Rs m1,48210,858 13.6%   
Long term debt Rs m041 0.0%   
Total assets Rs m2,07711,591 17.9%  
Interest coverage x6.7260.9 2.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.1 1,198.9%   
Return on assets %2.614.1 18.5%  
Return on equity %3.015.0 20.1%  
Return on capital %4.315.2 28.3%  
Exports to sales %01.5 0.0%   
Imports to sales %24.521.0 116.5%   
Exports (fob) Rs mNA19 0.0%   
Imports (cif) Rs m659263 250.4%   
Fx inflow Rs m1719 88.7%   
Fx outflow Rs m673264 255.2%   
Net fx Rs m-656-244 268.4%   
CASH FLOW
From Operations Rs m90236 38.2%  
From Investments Rs m105-224 -46.7%  
From Financial Activity Rs m-14-27 53.0%  
Net Cashflow Rs m181-15 -1,219.6%  

Share Holding

Indian Promoters % 0.0 64.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 0.2 1,900.0%  
FIIs % 0.1 9.7 1.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 26.1 81.2%  
Shareholders   4,783 54,701 8.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   TTK HEALTHCARE  VENUS REMEDIES  STERLING BIOTECH  ELDER PHARMA  AUROBINDO PHARMA  

Compare FULFORD INDIA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS